Erratum: Detection of circulating tumour cells in gastric and hepatocellular carcinoma: A systematic review [Journal of International Medical Research, 41, 4, 923-933, 10.1177/0300060513489789];Detection of circulating tumour cells in gastric and hepatocellular carcinoma: A systematic review

Journal of International Medical Research

Volumn 41, Issue 4, 2013, Pages 923-933

  Gao, Ping ^a   Jiao, Shun Chang ^a   Bai, Li ^a   Wang, Huan ^a   Jing, Fang Fang ^a   Yang, Jun Lan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

circulating tumour cells; Gastric cancer; hepatocellular carcinoma; systematic review

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA;

ARTICLE; CANCER STAGING; CIRCULATING TUMOR CELL; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; GENETIC HETEROGENEITY; HUMAN; LIVER CELL CARCINOMA; METASTASIS FREE SURVIVAL; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; STOMACH CARCINOMA; SYSTEMATIC REVIEW;

EID: 84887344997     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060514545431     Document Type: Erratum

References (45)

1. Sethi N,Kang Y.Unraveling the complexity of metastasis - molecular understanding and targeted therapies.Nat Rev Cancer. 2011;11:735-748.
2. GLOBOCAN 2008. Cancer Fact Sheet. Stomach Cancer Incidence and Mortality Worldwide in 2008 - Summary, http://globocan.iarc.fr/factsheets/cancers/stomach.asp (2008, accessed 25 June 2013).
3. Di Bisceglie AM.Epidemiology and clinical presentation of hepatocellular carcinoma.J Vasc Interv Radiol. 2002;13:S169-S171.
4. Pantel K,Alix-Panabières C,Riethdorf S.Cancer micrometastases.Nat Rev Clin Oncol. 2009;6:339-351.
5. Rahbari NN,Aigner M,Thorlund K,et al.Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer.Gastroenterology. 2010;138:1714-1726.
6. Müller V,Alix-Panabières C,Pantel K.Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies.Eur J Cancer. 2010;46:1189-1197.
7. Antolovic D,Galindo L,Carstens A,et al.Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies.BMC Biotechnol. 2010;10:35-35.
8. Chechlinska M,Kowalewska M,Nowak R.Systemic inflammation as a confounding factor in cancer biomarker discovery and validation.Nat Rev Cancer. 2010;10:2-3.
9. Allard WJ,Matera J,Miller MC,et al.Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases.Clin Cancer Res. 2004;10:6897-6904.
10. Marrinucci D,Bethel K,Lazar D,et al.Cytomorphology of circulating colorectal tumor cells: a small case series.J Oncol. 2010;2010:861341-861341.
11. Fehm T,Braun S,Muller V,et al.A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.Cancer. 2006;107:885-892.
12. Moher D,Cook DJ,Eastwood S,et al.Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.Lancet. 1999;354:1896-1900.
13. Soeth E,Vogel I,Röder C,et al.Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR.Cancer Res. 1997;57:3106-3110.
14. Yeh KH,Chen YC,Yeh SH,et al.Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19) - possible clinical significance in advanced gastric cancer.Anticancer Res. 1998;18:1283-1286.
15. Noh YH,Im G,Ku JH,et al.Detection of tumor cell contamination in peripheral blood by RT-PCR in gastrointestinal cancer patients.J Korean Med Sci. 1999;14:623-628.
16. Nishida S,Kitamura K,Ichikawa D,et al.Molecular detection of disseminated cancer cells in the peripheral blood of patients with gastric cancer.Anticancer Res. 2000;20:2155-2159.
17. Majima T,Ichikura T,Takayama E,et al.Detecting circulating cancer cells using reverse transcriptase-polymerase chain reaction for cytokeratin mRNA in peripheral blood from patients with gastric cancer.Jpn J Clin Oncol. 2000;30:499-503.
18. Miyazono F,Natsugoe S,Takao S,et al.Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery.Ann Surg. 2001;233:189-194.
19. Obayashi T,Taniguchi H,Mugitani T,et al.Safety and utility of autologous blood transfusion for resection of metastatic liver tumor.Hepatogastroenterology. 2001;48:812-817.
20. Sumikura S,Ishigami S,Natsugoe S,et al.Disseminated cancer cells in the blood and expression of sialylated antigen in gastric cancer.Cancer Lett. 2003;200:77-83.
21. Seo JH,Choi CW,Kim BS,et al.Follow-up study of peripheral blood carcinoembryonic antigen mRNA using reverse transcription-polymerase chain reaction as an early marker of clinical recurrence in patients with curatively resected gastric cancer.Am J Clin Oncol. 2005;28:24-29.
22. Illert B,Fein M,Otto C,et al.Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis.Scand J Gastroenterol. 2005;40:843-849.
23. Uen YH,Lin SR,Wu CH,et al.Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma.Clin Chim Acta. 2006;367:55-61.
24. Wu CH,Lin SR,Yu FJ,et al.Development of a high-throughput membrane-array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers.Int J Cancer. 2006;119:373-379.
25. Koga T,Tokunaga E,Sumiyoshi Y,et al.Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.Hepatogastroenterology. 2008;55:1131-1135.
26. Yie SM,Lou B,Ye SR,et al.Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.Ann Surg Oncol. 2008;15:3073-3082.
27. Saad AA,Awed NM,Abd Elkerim NN,et al.Prognostic significance of E-cadherin expression and peripheral blood micrometastasis in gastric carcinoma patients.Ann Surg Oncol. 2010;17:3059-3067.
28. National Cancer Institute at the National Institutes of Health. Stages of Gastric Cancer, http://www.cancer.gov/cancertopics/pdq/treatment/gastric/Patient/page2 (accessed 11 June 2013).
29. Louha M,Poussin K,Ganne N,et al.Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer.Hepatology. 1997;26:998-1005.
30. Matsumura M,Shiratori Y,Niwa Y,et al.Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma.J Hepatol. 1999;31:332-339.
31. Wong IH,Lau WY,Leung T,et al.Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.Clin Cancer Res. 1999;5:4021-4027.
32. Wong IH,Lau WY,Leung T,et al.Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring.Cancer Lett. 2000;156:141-149.
33. Kienle P,Weitz J,Klaes R,et al.Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma.Arch Surg. 2000;135:213-218.
34. Miyamoto A,Nagano H,Sakon M,et al.Clinical application of quantitative analysis for detection of hematogenous spread of hepatocellular carcinoma by real-time PCR.Int J Oncol. 2001;18:527-532.
35. Witzigmann H,Geissler F,Benedix F,et al.Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.Surgery. 2002;131:34-43.
36. Gross-Goupil M,Saffroy R,Azoulay D,et al.Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma.Ann Surg. 2003;238:241-248.
37. Cillo U,Navaglia F,Vitale A,et al.Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.Clin Chim Acta. 2004;347:129-138.
38. Jeng KS,Sheen IS,Tsai YC.Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.Arch Surg. 2004;139:1055-1060.
39. Jeng KS,Sheen IS,Tsai YC.Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?.Am J Gastroenterol. 2004;99:1503-1509.
40. Morimoto O,Nagano H,Miyamoto A,et al.Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.Surg Today. 2005;35:1033-1041.
41. Ikeguchi M,Kaibara N.Detection of circulating cancer cells after a gastrectomy for gastric cancer.Surg Today. 2005;35:436-441.
42. Hiraiwa K,Takeuchi H,Hasegawa H,et al.Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers.Ann Surg Oncol. 2008;15:3092-3100.
43. Matsusaka S,Chìn K,Ogura M,et al.Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer.Cancer Sci. 2010;101:1067-1071.
44. Buyse M,Sargent DJ,Grothey A,et al.Biomarkers and surrogate end points - the challenge of statistical validation.Nat Rev Clin Oncol. 2010;7:309-317.
45. Rogosnitzky M,Danks R.Validation of blood testing for K-ras mutations in colorectal and pancreatic cancer.Anticancer Res. 2010;30:2943-2947.